General discussion, page-3865

It is good to have a look at the IHL thread every now and then. Some very good analyst on how the future is looking, and lots of support. One of the better companies threadwise on this platform.

The science and the direction the company is going in has not changed. The share price has tripled over the past few months. A bit of a breather and some volatility is to be expected and normal.

Now remember the market cap at the moment is based all on potential and oil sales. So far we have not had any drug touch a human. This is really important to remember. We are still early in the development phase. To have the market cap we do at this stage in development shows investors have lots of confidence in the future.

I would think we will mark time in the present trading range until we get some news that busts us out. Just like any other company. When we start Phase 1 and 2 in human trials we will see the normal rise and fall on news (all normal behavior) and rerates when we get statistically significant data. If the science works (and there is plenty of sources already showing it does) the market cap will grow significantly, and interest in IHL will grow. More buyers, more volume in trade yielding higher prices.

The future is looking pretty bright, the past has shown solid performance, we just need the patience to sit back and wait until the science proves its worth.